Jr, W., Robinson, B., Gagel, R., Dralle, H., Fagin, J., Santoro, M., . . . Schlumberger, M. (2012). Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply.
Chicago Style (17th ed.) CitationJr, W., et al. Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply. 2012.
MLA (9th ed.) CitationJr, W., et al. Treatment of Metastatic Medullary Thyroid Cancer With Vandetanib: Need to Stratify Patients on Basis of Calcitonin Doubling Time Reply. 2012.
Warning: These citations may not always be 100% accurate.